Ser3486
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.5.9.3
Powered by Cell Signaling Technology
Home > Phosphorylation Site Page: > Ser3486  -  SHARP (human)

Site Information
QPAPKQDssPHLTSQ   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 455623

In vivo Characterization
Methods used to characterize site in vivo:
[32P] bio-synthetic labeling ( 2 ) , mass spectrometry ( 1 ) , mutation of modification site ( 2 )
Disease tissue studied:
HER2 positive breast cancer ( 1 ) , luminal A breast cancer ( 1 ) , luminal B breast cancer ( 1 ) , breast cancer, surrounding tissue ( 1 ) , breast cancer, triple negative ( 1 )
Relevant cell line - cell type - tissue:
293 (epithelial) ( 2 ) , breast ( 1 )

Upstream Regulation
Putative in vivo kinases:
PAK1 (human) ( 2 )
Kinases, in vitro:
PAK1 (human) ( 2 )

Downstream Regulation
Effects of modification on biological processes:
transcription, altered ( 2 )

References 

1

Mertins P, et al. (2016) Proteogenomics connects somatic mutations to signalling in breast cancer. Nature 534, 55-62
27251275   Curated Info

2

Vadlamudi RK, et al. (2005) An essential role of Pak1 phosphorylation of SHARP in Notch signaling. Oncogene 24, 4591-6
15824732   Curated Info